HSD17B14 and metabolic dysfunction-associated steatohepatitis: Moreover, the intrahepatic expression of HSD17B14 (also known as DHRS10, a member of the 17 be-ta-hydroxysteroid dehydrogenase superfamily) was negatively correlated with NASH severity and involved in the regulation of retinol and fatty acid metabolism (Govaere et al., 2020).